Get started
Author

Katsuhiro Shono

Observed names: K Shono, K. Shono, Katsuhiro Sho‐no
ORCID: 0000-0002-5163-0163
Observed ORCID: 0000-0002-5163-0163
OpenAlex ID: A5045430375
Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia
2018 · Masahiro Sakaguchi, Hiroki Yamaguchi, et al. · Blood Advances · 127
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
2021 · Satoshi Wakita, Masahiro Sakaguchi, et al. · Blood Advances · 116
D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations
2017 · Shunsuke Yui, Saiko Kurosawa, et al. · Annals of Hematology · 50
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia
2019 · Masahiro Sakaguchi, Hiroki Yamaguchi, et al. · International Journal of Hematology · 35
The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia
2020 · Masahiro Sakaguchi, Nana Nakajima, et al. · Leukemia Research Reports · 31
PDF
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
2023 · Satoshi Wakita, Atsushi Marumo, et al. · Cancer Science · 28
Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha
2016 · Saiko Kurosawa, Hiroki Yamaguchi, et al. · Transplantation and Cellular Therapy · 27
PDF
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis
2023 · Takashi Toya, Kota Mizuno, et al. · Blood Advances · 20
PDF
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis
2019 · Kanto Study, Takayoshi Tachibana, et al. · Leukemia · 19
Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT
2020 · Yu Akahoshi, Satoshi Nishiwaki, et al. · Bone Marrow Transplantation · 18
Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML
2004 · C Ohwada, C Nakaseko, et al. · Bone Marrow Transplantation · 18
Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation
2021 · Saiko Kurosawa, Takuhiro Yamaguchi, et al. · Journal of Cancer Survivorship · 15
Acute Myelogenous Leukemia with Leptotrichia trevisanii Bacteremia
2013 · Jin Kumagai, Yasuo Takiguchi, et al. · Internal Medicine · 15
PDF
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study
2019 · Shinichi Kako, Yoshinobu Kanda, et al. · American Journal of Hematology · 14
PDF
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort
2019 · Chikako Ohwada, Emiko Sakaida, et al. · Transplantation and Cellular Therapy · 14
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant
2016 · Yusuke Isshiki, Keiko Ono, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis
2016 · Yasumasa Sugita, Chikako Ohwada, et al. · Clinica Chimica Acta · 13
Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma
2018 · Kensuke Kayamori, Katsuhiro Shono, et al. · Hematology · 12
PDF
Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis
2023 · Kaito Harada, Makoto Onizuka, et al. · International Journal of Infectious Diseases · 9
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis
2020 · Takayoshi Tachibana, Junya Kanda, et al. · Transplantation and Cellular Therapy · 9
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation—a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT
2021 · Yu Akahoshi, Yasuyuki Arai, et al. · Bone Marrow Transplantation · 8
Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine
2020 · Taku Kikuchi, Takehiko Mori, et al. · International Journal of Hematology · 8
Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation
2019 · Ryo Shimizu, Masahiro Takeuchi, et al. · Annals of Hematology · 8
The occurrence of second neoplasms after treatment with tyrosine kinase inhibitors for chronic myeloid leukemia
2013 · Emi Togasaki-Yoshimoto, Katsuhiro Shono, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma
2015 · S Yano, T Mori, et al. · Bone Marrow Transplantation · 7
Works count: 64
Citation count: 713
H-index: 14
I10-index: 18
Year
Topic
Type